Express Scripts Holding ROA 2006-2018 | ESRX

Current and historical return on assets (ROA) values for Express Scripts Holding (ESRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Express Scripts Holding ROA for the three months ending September 30, 2018 was 8.94%.
Express Scripts Holding ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $4.90B $55.44B 9.00%
2018-06-30 $4.67B $54.68B 8.75%
2018-03-31 $4.60B $53.41B 8.78%
2017-12-31 $4.52B $54.26B 8.73%
2017-09-30 $3.63B $51.21B 7.09%
2017-06-30 $3.51B $50.51B 6.87%
2017-03-31 $3.43B $51.06B 6.70%
2016-12-31 $3.41B $51.75B 6.66%
2016-09-30 $2.74B $50.91B 5.33%
2016-06-30 $2.68B $50.86B 5.18%
2016-03-31 $2.56B $51.11B 4.92%
2015-12-31 $2.48B $53.24B 4.74%
2015-09-30 $2.29B $52.00B 4.36%
2015-06-30 $2.21B $51.87B 4.18%
2015-03-31 $2.12B $51.91B 3.97%
2014-12-31 $2.01B $53.75B 3.74%
2014-09-30 $1.93B $53.44B 3.60%
2014-06-30 $1.77B $54.63B 3.29%
2014-03-31 $1.80B $52.75B 3.34%
2013-12-31 $1.85B $53.55B 3.38%
2013-09-30 $1.85B $54.76B 3.31%
2013-06-30 $1.81B $54.58B 3.21%
2013-03-31 $1.42B $55.59B 2.48%
2012-12-31 $1.31B $58.11B 2.72%
2012-09-30 $1.10B $57.31B 2.92%
2012-06-30 $1.03B $58.06B 3.97%
2012-03-31 $1.22B $19.61B 8.64%
2011-12-31 $1.28B $15.61B 10.76%
2011-09-30 $1.32B $10.87B 12.42%
2011-06-30 $1.29B $10.24B 12.40%
2011-03-31 $1.25B $10.71B 11.63%
2010-12-31 $1.18B $10.56B 10.74%
2010-09-30 $1.08B $10.20B 9.47%
2010-06-30 $0.97B $11.48B 8.55%
2010-03-31 $0.87B $11.80B 7.98%
2009-12-31 $0.83B $11.93B 8.78%
2009-09-30 $0.81B $10.23B 10.38%
2009-06-30 $0.82B $9.80B 12.39%
2009-03-31 $0.81B $5.71B 15.06%
2008-12-31 $0.78B $5.51B 14.62%
2008-09-30 $0.71B $5.30B 13.50%
2008-06-30 $0.65B $5.08B 12.56%
2008-03-31 $0.61B $5.35B 11.87%
2007-12-31 $0.57B $5.26B 11.12%
2007-09-30 $0.58B $4.98B 11.36%
2007-06-30 $0.55B $5.03B 10.78%
2007-03-31 $0.50B $5.20B 9.89%
2006-12-31 $0.48B $5.11B 9.22%
2006-09-30 $0.44B $5.02B 8.36%
2006-06-30 $0.43B $5.05B 8.64%
2006-03-31 $0.42B $5.43B 9.08%
2005-12-31 $0.40B $5.49B 9.53%
Sector Industry Market Cap Revenue
Medical Medical Services $54.638B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $6.920B 21.69
PRA Health Sciences (PRAH) United States $6.277B 25.63
Charles River Laboratories (CRL) United States $6.012B 21.08
Premier (PINC) United States $5.275B 17.90
INC Research Holdings (SYNH) United States $4.800B 19.38
HealthEquity (HQY) United States $4.740B 99.21
Teladoc (TDOC) United States $3.711B 0.00
AMN Healthcare Services Inc (AMN) United States $2.883B 19.78
NovoCure (NVCR) Jersey $2.674B 0.00
BioTelemetry (BEAT) United States $2.016B 35.61
Medpace Holdings (MEDP) United States $1.851B 22.91
Healthways (TVTY) United States $1.480B 18.20
Intrexon (XON) United States $1.304B 0.00
IKang Healthcare (KANG) China $1.169B 58.03
CareDx (CDNA) United States $1.020B 0.00
Natera (NTRA) United States $0.957B 0.00
China Cord Blood (CO) China $0.802B 21.29
Apollo Medical Holdings (AMEH) United States $0.635B 0.00
Surgery Partners (SGRY) United States $0.618B 0.00
Establishment Labs Holdings (ESTA) $0.521B 0.00
Civitas Solutions (CIVI) United States $0.516B 10.18
OncoCyte (OCX) United States $0.069B 0.00
Interpace Diagnostics (IDXG) United States $0.032B 0.00
Cancer Genetics (CGIX) United States $0.013B 0.00
OpGen (OPGN) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00